首页> 外文OA文献 >Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

【2h】

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

机译：Custirsen（OGX-011）的I / II期试验（一种簇蛋白抑制剂）与吉西他滨和铂类药物联合治疗之前未经治疗的晚期非小细胞肺癌患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Laskin Janessa J.; Nicholas Garth; Lee Christopher; Gitlitz Barbara; Vincent Mark; Cormier Yvon; Stephenson Joe; Ung Yee; Sanborn Rachel; Pressnail Bryn; Nugent Francis; Nemunaitis John; Gleave Martin E.; Murray Nevin; Hao Desiree;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer [J] . LaskinJ.J., NicholasG., LeeC., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第3期

机译：在以前未经治疗的晚期非小细胞肺癌患者中，使用簇蛋白抑制剂卡斯汀（OGX-011）联合吉西他滨和铂方案进行I / II期临床试验
2. Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpress [J] . Zinner RG, Glisson BS, Fossella FV, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2004,第1期

机译：曲妥珠单抗联合顺铂和吉西他滨治疗Her2过表达，未治疗的晚期非小细胞肺癌患者：II期试验报告和关于最佳鉴定Her2过表达患者的发现
3. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. [J] . Fossella FV, DeVore R, Kerr RN, Journal of Clinical Oncology . 2000,第12期

机译：多西他赛与长春瑞滨或异环磷酰胺在之前接受过含铂化疗方案治疗的晚期非小细胞肺癌患者中的随机III期试验。 TAX 320非小细胞肺癌研究组。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer [O] . Seigo Minami, Takashi Kijima, Takayuki Shiroyama, 2013

机译：紫杉醇和卡铂联合吉西他滨开关维持治疗与吉西他滨和卡铂联合吉西他滨持续维持治疗的随机II期试验在先前未治疗的晚期非小细胞肺癌中
7. B1-02: A Phase 1-2 study of the anti-sense oligonucleotide OGX-011 in combination with a platinum/gemcitabine regimen as first-line therapy for advanced non-small cell lung cancer [O] . Laskin Janessa, Hao Desiree, Canil Christina, 2007

机译：B1-02：反义寡核苷酸OGX-011与铂/吉西他滨方案联合作为晚期非小细胞肺癌的一线治疗的1-2期研究

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅